A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation

BACKGROUND: We conducted a placebo-controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation. METHODS: We compared azithromycin (250 mg alternate days, 12 weeks) with placebo. Primary outcome was FEV(1) change at 12 weeks. RESULTS: 48 patients were...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Thorax
Main Authors: Corris, Paul A, Ryan, Victoria A, Small, Therese, Lordan, James, Fisher, Andrew J, Meachery, Gerard, Johnson, Gail, Ward, Chris
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2015
Assuntos:
Lung Transplantation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4413845/
https://ncbi.nlm.nih.gov/pubmed/25714615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2014-205998
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares